Lingxi Nan

5PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionTumour immunologyCancer cell biologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 20, 2024
CircRNome-wide characterisation reveals the promoting role of circAATF in anti-PD-L1 immunotherapy of gallbladder carcinoma.

Yueqi Wang, Shengli Li, Xiaobo Bo

|Jun 18, 2020
Prediction Efficacy for Clinical Outcome of Prognostic Nutritional Index in Patients with Resectable Biliary Tract Cancer Depends on Sex and Obstructive Jaundice Status.

Jie Wang, Xiaobo Bo, Min Li

|Jan 12, 2020
High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer.

Xiaobo Bo, Jie Wang, Changcheng Wang

|Dec 27, 2019
Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.

Jie Wang, Xiaobo Bo, Lingxi Nan

|Nov 16, 2019
Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer.

Jie Wang, Xiaobo Bo, Changcheng Wang

Pageof 1

Frequent Collaborators

2 joint publications

Yueqi Wang

1 joint publications

Shengli Li